Calidi Biotherapeutics (CLDI) Long-Term Investments (2021 - 2023)
Calidi Biotherapeutics' quarterly Long-Term Investments came in at $230000.0 in Q4 2023, down 99.46% year-on-year from $42.5 million in Q4 2022, and down 82.17% quarter-over-quarter from $1.3 million in Q3 2023.
Calidi Biotherapeutics has reported Long-Term Investments for 3 years, with the latest figure at $230000.0 in Q4 2023.
- For the quarter ending Q4 2023, Long-Term Investments fell 99.46% year-over-year to $230000.0; the trailing twelve-month figure through Dec 2023 stood at $230000.0 (down 99.46% YoY), and the FY2023 full-year result was $230000.0, down 99.46% from the prior year.
- Long-Term Investments for Q4 2023 stood at $230000.0, down from $1.3 million in the prior quarter.
- The five-year high for Long-Term Investments was $230.2 million in Q2 2022, with the low at $230000.0 in Q4 2023.
- Average Long-Term Investments over 3 years is $95.8 million, with a median of $42.9 million recorded in 2023.
- Peak annual rise in Long-Term Investments reached 81.23% in 2023, while the deepest fall reached 99.46% in 2023.
- Tracing CLDI's Long-Term Investments over 3 years: stood at $230.0 million in 2021, then sank by 81.54% to $42.5 million in 2022, then sank by 99.46% to $230000.0 in 2023.
- The last three Long-Term Investments figures came in at $230000.0 (Q4 2023), $1.3 million (Q3 2023), and $43.2 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 9.79 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 1.29 Mn |
| Jun 30, 2023 | 43.21 Mn |
| Mar 31, 2023 | 42.91 Mn |
| Dec 31, 2022 | 42.45 Mn |
| Sep 30, 2022 | 41.68 Mn |
| Jun 30, 2022 | 230.18 Mn |
| Mar 31, 2022 | 230.02 Mn |
| Dec 31, 2021 | 230.00 Mn |